loader2
Partner With Us NRI

Chandra Bhagat Pharma Ltd

Company details

107.85
107.85
83.00
144.80
6M Return 5.84%
1Y Return 5.84%
Mkt Cap.(Cr) 81.37
Volume 1,000
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 1,000

Open Free Demat Account Online with ICICIDIRECT

FINANCIALS

Sales

Operating Profit

Profit after Tax

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after Tax

PE

Debt/Equity

P BV

COMPARISION

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 26.68 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 9,798.25 -19,599.12
LAST 3M 26,543.67 -19,477.65
LAST 6M 49,511.94 55,323.78
LAST 12M 182,243.81 -111,295.16

INFORMATION

Stock PE (TTM)

101.75

Promoter Holding

69.09%

Book Value

35.3549

ROCE

8.14%

ROE

3.04%

Description

  • Chandra Bhagat Pharma Limited was incorporated as a private limited company with the name `Chandra Bhagat Pharma Private Limited` at Mumbai on March 10, 2003. Consequent upon the conversion of the Company from Private Limited Company to Public Limited Company, the name of the Company was changed to `Chandra Bhagat Pharma Limited` on March 20, 2019. Inspirited by its founder Late Shree Chandravadan Bhagat`s sense of personal mission, the company is driven to fill the gap in pharma sector especially in critical lifesaving medicines in India. The Company was incorporated on March 10, 2003 by Mr. Hemant Bhagat and Late. Shree Chandravadan Bhagat. On April 1, 2003, the company acquired the going concern business of M/s. Chandra Bhagat Corporation (`partnership firm`) along with all its assets and liabilities. Consequently, the company issued equity shares to respective partners of M/s. Chandra Bhagat Corporation against the acquisition of going concern business along with all its assets and liabilities. The promoter Mr. Hemant Bhagat decided to continue on the footsteps of his father Late Shree Chandravadan Bhagat by focusing on marketing of life saving medicines like Antibiotics, Antineoplastic, Cardiovascular, Hormones etc. and set up the company`s marketing force in order to wider the product portfolio. Subsequently in the year 2004, the promoter Mr. Pranav Bhagat son of Mr. Hemant Bhagat, being third generation also joined the business and decided to market the pharmaceuticals and special chemical products in domestic as well as in international market. The promoters have a combined experience of more than 41 years in the Pharmaceutical products, Bulk drugs and vaccines. Driven by the passion for building an integrated pharmaceutical company, backed by their more than two decades of experience, the Promoters have been the pillars of the Company`s growth since inception and have built a strong value system for the Company. With their enriching experience and progressive thinking, the company aims to continue to grow in the pharmaceutical and bulk drugs in India and abroad.

No Data Found

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 2000
BSE Code : 542934
NSE Code :
Book Closure Date (Month) :
BSE Group : M
ISIN : INE07QQ01016

ICICIdirect Chandra Bhagat Pharma Ltd FAQ

You can buy Chandra Bhagat Pharma Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Chandra Bhagat Pharma Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Jan 30, 2023 04:01 PM the closing price of Chandra Bhagat Pharma Ltd was ₹ 107.85.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Jan 30, 2023 04:01 PM, the market cap of Chandra Bhagat Pharma Ltd stood at ₹ 81.37.
The latest PE ratio of Chandra Bhagat Pharma Ltd as of Jan 30, 2023 04:01 PM is 101.75
The latest PB ratio of Chandra Bhagat Pharma Ltd as of Jan 30, 2023 04:01 PM is 0.33
The 52-week high of Chandra Bhagat Pharma Ltd is ₹ 144.80 while the 52-week low is ₹ 83.00

Download Our App

market app
market app